IL-6, for example, is significantly elevated in HD patients [25], and it is well accepted that, on the one hand, IL-6 can enhance inflammation, but on the other hand, i.e., in the absence of the suppressor of cytokine signaling 3 (SOCS3), it can induce an anti-inflammatory response [26]). The gene discussed is SOCS3; the disease is Huntington disease.